Extemporaneously prepared medications must always be chemically stable, physiologically suitable and result in a positive therapeutic outcome. At MEDISCA, we recognise the need for compounded medications to be supported by scientific research and robust stability studies.
Our online BUD Quarterly sums up the results of our stability-indicating studies, using MEDISCA’s oral bases. The studies are validated and conducted in association with pediatrics healthcare and educational institutions. We are continuously building the database of stability-indicating studies based on customer requests, market needs and science advancement.
To ensure that compounded preparations are made and used safely, published data and suitable testing must be considered. This BUD Databank provides the results of our stability-indicating studies, using our line of dye-free oral vehicles. Through strategic partnerships with renowned institutions, we offer a wide variety of stability data tested in various dispensers and container closures, using both forms of APIs: pure powder and commercial drugs.
Beyond Used Date (BUD) studies are an important investment for MEDISCA as they provide significant information on the durability and potency of compounded medications over time. In collaboration with various institutions in the US and Canada, MEDISCA is continuously developing a comprehensive database of stability studies using our topical bases. The databank below releases the results of some of our published studies.
Sign up for free email updates to receive the latest news about products, services and events from MEDISCA.
Participate in our MD Dispenser survey now!
You have successfully added to the cart.
Please note that MEDISCA will no longer accept any returns and will not issue any credits for active pharmaceutical ingredients (APIs).
Copyright® 1986-2019 Medisca Inc.
All rights reserved
Back to Top